Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?
Publication
, Journal Article
Khouri, MG; Griffin, JM
Published in: Circulation
January 27, 2026
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 27, 2026
Volume
153
Issue
4
Start / End Page
226 / 229
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Khouri, M. G., & Griffin, J. M. (2026). Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy? Circulation, 153(4), 226–229. https://doi.org/10.1161/CIRCULATIONAHA.125.078276
Khouri, Michel G., and Jan M. Griffin. “Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?” Circulation 153, no. 4 (January 27, 2026): 226–29. https://doi.org/10.1161/CIRCULATIONAHA.125.078276.
Khouri MG, Griffin JM. Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy? Circulation. 2026 Jan 27;153(4):226–9.
Khouri, Michel G., and Jan M. Griffin. “Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy?” Circulation, vol. 153, no. 4, Jan. 2026, pp. 226–29. Pubmed, doi:10.1161/CIRCULATIONAHA.125.078276.
Khouri MG, Griffin JM. Anti-Fibril Depleters: The Dawn of a New Treatment Era in Transthyretin Amyloid Cardiomyopathy? Circulation. 2026 Jan 27;153(4):226–229.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
January 27, 2026
Volume
153
Issue
4
Start / End Page
226 / 229
Location
United States
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology